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Abstract21
Leishmania mexicana has a large family of cyclin-dependent kinases (CDKs) that reflect the22
complex interplay between cell cycle and life cycle progression. Evidence from previous23
studies indicated that Cdc2 related kinase 3 (CRK3) in complex with the cyclin CYC6 is a24
functional homologue of the major cell cycle regulator CDK1, yet definitive genetic evidence25
for an essential role in parasite proliferation is lacking. To address this, we have implemented26
an inducible gene deletion system based on a dimerised Cre recombinase (diCre) to target27
CRK3 and elucidate its role in the cell cycle of L. mexicana. Induction of diCre activity in28
promastigotes with rapamycin resulted in efficient deletion of floxed CRK3, resulting in29
G2/M growth arrest. Co-expression of a CRK3 transgene during rapamycin-induced deletion30
of CRK3 resulted in complementation of growth, whereas expression of an active site31
CRK3
T178E
mutant did not, showing that protein kinase activity is crucial for CRK3 function.32
Inducible deletion of CRK3 in stationary phase promastigotes resulted in attenuated growth in33
mice, thereby confirming CRK3 as a useful therapeutic target and diCre as a valuable new34
tool for analysing essential genes in Leishmania.35
36
Introduction37
38
The leishmaniases, diseases caused by protozoan parasites of the genus Leishmania, have39
diverse clinical manifestations dependent on the species and host immune response.40
Leishmaniasis is a substantial public health issue, causing an estimated 40,000 deaths41
annually and approximately 0.2 to 0.4 and 0.7 to 1.2 million visceral and cutaneous42
manifestations of the disease respectively (Alvar et al., 2012). Existing drug therapies are43
problematic due to high treatment costs, toxicity and undesirable administration routes,44
making the development of novel and effective drug therapies to expand the current45
repertoire crucial. Phenotypic strategies to identify drug targets in the mammalian infective46
amastigote life cycle stage are of particular importance for drug discovery programs.47
48
As unicellular organisms, Leishmania depend on stringent control of cellular division to49
propagate and maintain infection. Protein kinases elicit pronounced effects on the Leishmania50
cell cycle by regulation of cell signalling pathways, and a number of protein kinases have51
been identified that are essential for promastigote viability (Wang et al., 2005; Dacher et al.,52
2014). The cyclin-dependent kinases (CDK) are of particularly interest due to their pivotal53
roles as cell cycle regulators. The use of CDK inhibitors in cancer therapy (Cicenas and54
Valius, 2011; Knapp and Sundström, 2014) and the relative expansion of this protein family55
in Leishmania relative to other unicellular organisms distinguishes them as suitable drug56
targets. In particular, the CDK related kinase CRK3 has been demonstrated as being57
important for regulation of the L. mexicana promastigote cell cycle by existing genetic58
manipulation techniques and cell cycle arrest following treatment with CDK inhibitors (Grant59
et al. 1998; Hassan et al. 2001; Grant et al. 2004). Recombinant protein kinase activity assays60
(Gomes et al., 2010) and yeast recovery mutants (Wang et al., 1998) have provided further61
validation of CRK3 as a drug target, leading to the identification and synthesis of a number of62
CRK3 inhibitors (Grant et al., 2004; Cleghorn et al., 2011; Walker et al., 2011; Goyal et al.,63
ěH]QtþNRYiet al., 2015). Regulation of CRK3 expression in L. mexicana is desirable to64
further assess its function in both procyclic promastigote and amastigote life cycle stages,65
however, no system exists for conditional deletion of essential genes. Recent application of66
plasmid shuffle methodology has addressed this issue by enabling the generation of partial67
null mutants to further study essentiality and important residues within coding sequences68
(Morales et al., 2010; Dacher et al., 2014), however the gene is not deleted and this prevents69
phenotyping of a null mutant.70
71
To address this limitation, we have implemented a rapamycin-inducible gene deletion system72
using a dimerised Cre recombinase (diCre) (Jullien et al., 2003; Collins et al., 2013;73
Andenmatten et al., 2013) to target CRK3 and elucidate its role in the cell cycle of L.74
mexicana. L. mexicana is generally diploid (Rogers et al., 2011) and both CRK3 alleles were75
replaced with a ‘floxed’ CRK3 open reading frame and the diCre coding sequence through76
promastigote transfection and homologous recombination. This system was used to77
conditionally delete CRK3 during promastigote growth and so prove that CRK3 mediates the78
transition through G2/M. Induced loss of CRK3 was complemented by expression of a CRK379
transgene but not by expression of an inactive site (T178E) CRK3 mutant, showing that80
protein kinase activity is crucial for CRK3 function. Significantly, conditional deletion of81
CRK3 in stationary phase promastigotes and subsequent attenuation during murine infection82
demonstrates that CRK3 activity is essential for establishing infection. This system represents83
a new method to directly assess whether a gene is essential to parasite viability and provides84
novel insight into the function of essential genes in Leishmania.85
86
Results87
88
DiCre activity is tightly regulated in L. mexicana promastigotes and amastigotes89
To test the activity of diCre in L. mexicana promastigotes, a reporter cell line was generated90
by integration of a loxP-flanked GFP into the ribosomal locus: [SSU GFP
Flox
]. This cell line91
was transfected with a diCre construct containing the two dimerizable Cre recombinase92
subunits with the homologous flanks of crk3 to generate the heterozygous line93
ǻcrk3::DICRE/CRK3 [SSU GFPFlox]). Integration of the diCre construct at the CRK3 locus94
was confirmed by PCR analysis (Fig. S1A). No effect on the growth of SSU GFP
Flox
or95
ǻcrk3::DICRE/CRK3 [SSU GFPFlox] was observed in the presence of the dimerization ligand,96
rapamycin, up to the highest dose of 250 nM (Fig. S1B). GFP excision following incubation97
with increasing concentrations of rapamycin was investigated by PCR using specific primers98
flanking GFP. A single 1.45 kb PCR product, the floxed GFP fragment, was detected in the99
absence of rapamycin, whilst a 0.69 kb PCR product, representing the excised locus, was100
detected following rapamycin treatment only (Fig. 1A), indicating tight regulation of diCre101
DFWLYLW\ǻcrk3::DICRE/CRK3 [SSU GFPFlox] and [SSU GFPFlox] promastigotes grown for 5102
days in the presence or absence of increasing concentrations of rapamycin were analysed by103
flow cytometry to measure levels of GFP expression (Fig. 1B). Treatment of104
ǻcrk3::DICRE/CRK3 [SSU GFPFlox] promastigotes with greater than 5 nM rapamycin105
resulted in substantial loss of GFP expression compared with the untreated controls, whilst106
GFP expression in [SSU GFP
Flox
] was the same following growth in all concentrations of107
UDSDP\FLQ *)3 ORVV LQ ǻcrk3::DICRE/CRK3 [SSU GFPFlox] promastigotes grown in the108
presence or absence of 100 nM rapamycin for 5 days was further assessed by Western109
blotting of total protein extracts using anti-GFP antibody (Fig. 1C). Rapamycin treated110
promastigotes had considerably reduced GFP compared with the untreated controls, thereby111
demonstrating that gene loss results in reduced protein expression. These data also112
demonstrate that expression of diCre from the CRK3 locus is sufficient to efficiently excise113
the GFP transgene at rapamycin concentrations above 5 nM, and that no background diCre114
activity can be detected in the absence of ligand. 100 nM rapamycin was chosen as the115
optimum concentration to induce diCre activity in promastigotes whilst having no effect on in116
vitro cell growth.117
To test diCre functionality in amastigotes, infectious promastigotes of the experimental line118
ǻcrk3::DICRE/CRK3 [SSU GFPFlox] were inoculated into BALB/c footpads and amastigotes119
purified from the resulting lesion. Ex vivo amastigotes retained high levels of green120
fluorescence and were incubated with rapamycin for 24 hrs in Schneider’s medium prior to121
infection of bone-marrow derived macrophages. Efficient excision of GFP
Flox
was detected122
by PCR amplification of a 0.69 kb fragment representative of GFP loss in all rapamycin123
treated samples (Fig. 1D) and GFP
-
(non-fluorescent) amastigotes were observed by124
comparing images obtained through fluorescence live cell imaging (Fig. S1C). Residual125
GFP
+
amastigotes were still visible by microscopy (Fig. S1C) and could be detected by flow126
cytometry (Fig. S1D); this was possibly due to the slow replication rate of amastigotes127
leading to a low rate of GFP turnover. These data demonstrate inducible diCre activity in128
amastigotes.129
Inducible deletion of CRK3 in L. mexicana promastigotes130
The functional and efficient levels of diCre-mediated excision of GFP underpinned the131
development of a system for conditional deletion of essential genes. Gateway recombineering132
was used to flank appropriate diCre and loxP expression constructs with gene-specific,133
homologous flanks (Fig. S2). Plasmids were generated by this method to replace the two134
alleles of CRK3, an essential gene in L. mexicana (Hassan et al., 2001) (Fig S3A). The first135
allele of CRK3 was replaced with DICRE ǻcrk3::DICRE/CRK3) and the second allele of136
CRK3 was subsequently replaced with a floxed C-terminal GFP-tagged CRK3 version137
ǻcrk3::DICREǻcrk3::CRK3Flox; Figs. 2A and S3B). In addition, an mCherry red fluorescent138
protein coding sequence was incorporated downstream from the floxed CRK3-GFP to139
facilitate flow cytometry and microscopy analysis. Transfection resulted in multiple clones140
with the expected genetic modifications, as confirmed by PCR analysis (Fig. S3B).141
142
7KHJURZWKRISURPDVWLJRWHVIURPWZRǻcrk3::DICREǻcrk3::CRK3Flox clones were assessed143
following diCre-mediated excision induced with 100 nM rapamycin (Fig. 2B). Cells were144
counted over the course of 5 days, revealing a pronounced growth defect and reduction in cell145
number in rapamycin treated cells compared with uninduced controls. PCR analysis of146
promastigotes grown in the presence or absence of 100 nM rapamycin for 24 h and 48 h147
confirmed efficient loss of the CRK3 gene (Fig. 2C) by the amplification of a single 1.36 kb148
DNA fragment for both rapamycin treated clones. The retention of the 3.4 kb amplicon149
containing the CRK3 gene in both untreated clones is evidence that no background diCre150
activity can be detected in the absence of rapamycin. To test for loss of the CRK3-GFP151
protein, total protein extracts of clone 2 promastigotes grown for 96 h in the presence or152
absence of 100 nM rapamycin were analysed by Western blot analysis with anti-GFP153
antibody (Fig. 2D) Very low levels of protein were detected in the treated promastigotes154
compared to the untreated cells, confirming that the conditional gene loss leads to reduced155
protein levels. Treatment with 100 nM rapamycin did not result in any noticeable effect on L.156
mexicana promastigote growth (Fig. S1B), however the pronounced growth arrest arising157
from loss of the essential gene could possibly result in cellular stress that synergises with158
rapamycin. These data show that this is a viable genetic manipulation strategy and that loss of159
CRK3 resulted in growth arrest and reduced cell numbers, both phenotypes consistent with160
loss of an essential gene.161
162
Cell cycle analysis of CRK3-deficient promastigotes.163
164
Previous attempts to impair CRK3 function in Leishmania by treatment with protein kinase165
inhibitors may have resulted in off-target effects (Grant et al., 2004; Reichwald et al., 2008;166
Cleghorn et al., 2011; Jorda et al., 2011; Efstathiou et al. ěH]QtþNRYiet al., 2015).167
Here the utilisation of diCre mediated gene deletion enabled the effect of CRK3 depletion on168
the cell cycle to be investigated. Firstly, microscopic analysis of the cells at 96 h post-169
induction showed an accumulation of large, aberrant cells with altered organelle homeostasis170
as evidenced by the presence of cells with multiple flagella (Fig. 3A). DAPI labelling of such171
multi-flagellated cells to visualise cellular DNA revealed the presence of enlarged nuclei172
indicative of an arrest in mitosis. Interestingly, cells were also observed that lacked a nucleus173
but retained the kinetoplast (‘zoids’), a cell cycle defect observed previously by the treatment174
of promastigotes with CDK inhibitors (Grant et al., 2004). Secondly, flow cytometry was175
SHUIRUPHG WR GHWHUPLQH WKH RYHUDOO '1$ FRQWHQW RI ǻcrk3::DICREǻcrk3::CRK3Flox176
promastigotes grown in the presence or absence of 100 nM rapamycin for 72 and 96 h (Fig.177
3B). This analysis showed that conditional deletion of CRK3 resulted in the accumulation of178
cells with 4C DNA content, associated with cell cycle arrest at G2/M, whilst an increasing179
population of cells with DNA content <1C indicates the accumulation of zoids. Finally, to180
assess the rate of cell death occurring in CRK3-deficient cells a viability assay was performed181
on promastigotes after growth in the presence or absence of 100 nM rapamycin for 72 h182
(Figs. 3C & S4). After 72 h the proportion of propidium iodide positive cells (PI
+
) was183
around 40% indicating a high level of cell death, which likely resulted from the accumulation184
of anucleated zoids at this time point. Flow cytometry analysis of cell size (using forward185
scatter) was in agreement with the microscopy analysis and showed that CRK3 deficient cells186
were substantially larger than cells retaining the gene (Fig. S4). Taken together, these data187
provide evidence that CRK3 plays an essential role in regulating mitosis in replicating188
promastigotes.189
190
Active CRK3 is required for cell cycle progression in promastigotes191
We demonstrated that diCre could be used to efficiently delete a floxed copy of CRK3, so we192
exploited the efficiency of this system to further study gene function through193
complementation. Such a system was established by expressing a histidine-tagged CRK3194
(CRK3his) (Hassan et al.WUDQVJHQHLQǻcrk3:DICREǻcrk3::CRK3Flox promastigotes.195
No significant difference in growth was noted in the presence or absence of rapamycin over a196
5 day period (Fig. 4A). Efficient excision of floxed CRK3 in the induced culture was197
confirmed by PCR amplification of the diagnostic 1.36 kb fragment by 24 h post-treatment198
with 100 nM rapamycin (Fig. 4B). The proliferation of promastigotes, despite loss of floxed199
CRK3, indicates CRK3 WUDQVJHQHFRPSOHPHQWDWLRQ LQ WKH LQGXFHGǻcrk3 cell line. Previous200
studies have shown that recombinant L. mexicana CRK3
T178E
protein lacks H1 kinase activity201
(Gomes et al., 2010) and an L. major CRK3
T178E
mutant fails to complement a cdc2-33(ts)202
yeast mutant (Wang et al., 1998). To test whether active CRK3 is required for cell growth,203
we exploited this complementation approach by generation of the cell line204
ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E] expressing a T-loop residue mutated205
version of CRK3 from the ribosomal locus. Growth curves indicate that expression of the206
CRK3
T178E
transgene failed to complement the loss of CRK3
Flox
following induction with207
rapamycin (Fig. 4A, B) thereby demonstrating that CRK3
T178E
cannot rescue loss of active208
CRK3. The overall growth rate of both complementation mutants was reduced relative to the209
parental line (Table 1) and may explain the growth arrest at 72 h following excision of CRK3210
LQ ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E] compared with a more rapid onset of211
growth arrest in the parental line (Fig. 2B). These data show that active CRK3 is required for212
parasite growth. The CRK3 deficient cells were analysed by flow cytometry and fluorescence213
PLFURVFRS\ VKRZLQJ WKDW ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E] cells were214
blocked in G2/M (Fig. 4C) and were multi-nucleate and aberrant (Fig. 4D). These data are in215
agreement with the phenotype observed following excision of CRK3 in wild-type cells (Fig.216
3A & B), thereby indicating the importance of the T-loop in regulating CRK3 activity. Based217
on these results, we conclude that transgene complementation can be used to confirm the218
specificity of conditional deletion of essential genes and also to probe the function of genes219
following mutagenesis.220
221
CRK3 is essential for in vivo infection of murine hosts222
The lack of a conditional system to regulate expression of essential genes is a major obstacle223
for in vivo studies of essentiality, with such studies having crucial applications for drug target224
validation. To address this we tested if CRK3 activity is essential for survival of the parasite225
over the course of in vivo infection. Monitoring infection by detection of the light signal226
emitted from bioluminescent Leishmania using an in vivo imaging system (IVIS) is an227
established, longitudinal and non-invasive method to correlate signal with pathogen load228
(Lang et al., 2005; Lecoeur et al., 2007; Talmi-Frank et al., 2012; Vasquez et al., 2015). To229
assess the outcome of CRK3 loss on the proliferation of L. mexicana in vivo, bioluminescent230
lines were generated by transfection of L. mexicana wild-type and231
ǻcrk3::DICREǻcrk3::CRK3Flox promastigotes with a ribosomal integration construct232
encoding red-shifted firefly luciferase, Ppy RE9H (Branchini et al., 2010; McLatchie et al.,233
2013). Both lines were bioluminescent as determined by luciferase expression assays on234
ORJDULWKPLFVWDJHSURPDVWLJRWHV7KHUHVXOWLQJǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H]235
cell line produced 5 fold higher bioluminescence compared with the wild-type [SSU RE9H]236
control (Fig. S4). Footpad bioluminescence detected with an in vivo imaging system (IVIS)237
correlated well with parasite burden in mice infected with L. mexicana expressing Ppy RE9H238
(Fig. 5A; y = 4.8 + 0.43x, R
2
= 0.743 and p < 0.0001). The slope of the linear regression line239
(0.43) revealed smaller increases in bioluminescence with increasing parasite burden. This240
may be related to tissue absorbance of light in vivo or limited substrate availability with241
increasing numbers of amastigotes within the lesion. Nevertheless, these data show that242
parasite burdens can be predicted from bioluminescence and that IVIS could be used for the243
non-invasive monitoring of parasite growth in mice over 10 weeks of infection. Following244
WUHDWPHQWRIǻcrk3::DICREǻcrk3::CRK3Flox stationary phase promastigotes with rapamycin245
for 24 h the amplification of a 1.36 kb fragment (Fig. 5B) indicated that the majority of246
parasites had successfully excised floxed CRK3. The presence of small amounts of a 3.4 kb247
amplicon corresponding to the intact floxed CRK3 gene, however, also suggested that some248
SDUDVLWHVKDGUHWDLQHGWKHJHQH7KHVHVWDWLRQDU\SKDVHǻcrk3::DICREǻcrk3::CRK3Flox [SSU249
RE9H] promastigotes either rapamycin treated (+ Rap) or not treated (- Rap) were then250
inoculated into the footpads of BALB/c mice. The in vivo bioluminescence in footpads of251
PLFH LQIHFWHGZLWK WKH UDSDP\FLQWUHDWHGǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H] was252
significantly reduced compared to the uninduced control by 5 weeks post-infection (p253
<0.001) and this continued up to 9 weeks post-infection (p<0.005) (Fig. 5C, D). From 5 to 9254
weeks the bioluminescence from footpads infected with rapamycin-treated parasites255
increased 100-fold and was likely due to the proliferation of parasites that had not responded256
to rapamycin treatment and persisted in the lesion. To investigate this possibility, viable257
amastigotes were purified from the lesions of four mice at 10 weeks post-infection and258
analysed for the presence of CRK3
Flox
by PCR after a single round of in vitro culture (Fig.259
5E). A 3.4 kb PCR product containing CRK3 was amplified from all samples, indicating the260
persistence of parasites that had escaped diCRE mediated excision of CRK3.261
262
The ability of CRK3 deficient promastigotes to establish infection was further assessed by263
measuring footpad sizes at weekly intervals (Fig. 5F). The footpad sizes of mice infected with264
HLWKHUXQWUHDWHGRU UDSDP\FLQWUHDWHGǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H] parasites265
were similarly low until about 4 weeks post-infection. Subsequently, footpads containing266
untreated parasites increased steadily over the course of infection, whilst those infected with267
UDSDP\FLQWUHDWHGǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H] remained low until 9 weeks268
post infection. Comparison of the bioluminescence and lesion sizes suggest that there is a269
delay in lesion development despite parasite proliferation and that the lesions only increase270
VLJQLILFDQWO\ ZKHQ SDUDVLWH ORDG UHDFKHV D FHUWDLQ OHYHO HTXDWLQJ WR ELROXPLQHVFHQFH §7271
photons/sec); in the case of the untreated parasites this occurred from about 5 weeks while for272
rapamycin-treated parasites this level of parasite burden had still not been reached by 9273
weeks. Altogether these data show that loss of active CRK3 impairs the establishment of274
infection in vivo, and that a later resurgence of parasites likely results from a small population275
of cells which previously escaped CRK3 conditional deletion.276
277
Discussion278
279
We have developed an inducible system for the genetic manipulation of essential genes in280
Leishmania. Inducible diCre was used to demonstrate the requirement for CRK3 activity in281
the regulation of mitosis. A distinct growth defect was observed 48 h after induced deletion282
of CRK3 (Fig. 2) resulting in cells arrested in G2/M, as well as an accumulation of zoids and283
eventually a population of enlarged, multi-flagellated cells (Fig. 3). This phenotype was284
rescued by expression of a CRK3 transgene from the ribosomal locus, confirming that loss of285
CRK3 caused mitotic arrest (Fig. 4). Arrest in G2/M and the accumulation of zoids have286
previously been reported following incubation of L. mexicana promastigotes with the CRK3287
inhibitors flavopiridol (Hassan et al., 2001) and indirubin (Grant et al. 2004), showing288
correlation between genetic and chemical downregulation of CRK3 activity. In Trypanosoma289
brucei RNAi knockdown of the syntenic orthologue of CRK3 in the procyclic form also290
results in G2/M arrest and zoid formation (Tu and Wang, 2004), with the accumulation of291
such aberrant cells explained by the lack of a checkpoint controlling exit from mitosis and292
entry in cytokinesis (Ploubidou et al., 1999; Hammarton et al., 2003). Inducible deletion of293
CRK3 indicates that this checkpoint is also absent in L. mexicana promastigotes, resulting in294
impairment of mitotic progression, followed by re-initiation of G1 in the absence of295
cytokinesis. It appears that these abnormal cells can eventually undergo cytokinesis; however296
the daughter cell lacks a nucleus and is often multi-flagellated (see bi-flagellated zoid in Fig297
3A), whilst the high levels of cell death occurring 72 h after gene loss show that such progeny298
are not viable.299
300
CRK3 is active at different stages in the cell cycle by forming complexes with cyclin partners301
such as CYC6 and CYCA, therefore CRK3 deletion could impact the cell cycle at multiple302
stages. RNAi of the CYC6 in T. brucei procyclic forms results in growth arrest within 48 h of303
induction and the accumulation of zoids and cells in G2/M (Hammarton et al., 2003). A304
similar phenotype was found in this study with CRK3 inducible deletion, suggesting that the305
CRK3:CYC6 complex is involved in regulation of mitosis (Walker et al., 2011). Less is306
known about the activity of CRK3:CYCA. Protein expression assays of L. donovani CYC1307
(the functional orthologue of CYCA) demonstrates an increased abundance during S-phase308
(Banerjee et al., 2006) coupled with histone phosphorylation by an active CRK3:CYC1309
complex (Maity et al., 2011), which is suggestive of S-phase kinase activity. Active,310
recombinant L. mexicana CRK3:CYCA has also been engineered, with phosphorylation of311
the T-loop residue T178 by the CDK activating kinase (CAK) Civ-1 increasing activity312
(Gomes et al., 2010). The T178 residue is essential for CRK3 activity as T178E mutagenesis313
inhibits functional rescue in S. pombe (Wang 1998) and ablates kinase activity in314
recombinant CRK3
T178E
:CYCA (Gomes et al., 2010). The necessity of T178 was tested315
directly in this study, with excision of floxed CRK3 LQ WKH ǻcrk3::DICREǻcrk3::CRK3Flox316
[SSU CRK3
T178E
] line leading to cell cycle arrest in G2/M and zoid formation. The growth317
UDWH RI WKLV OLQH DQG ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3] were reduced when318
FRPSDUHG WR ǻcrk3::DICREǻcrk3::CRK3Flox (Table 1), indicative of generally reduced319
growth rate when expressing a transgene. Episomal complementation with CRK3 did not320
result in an observable growth defect (Hassan et al., 2001), but this may result from the321
modulation of the number of episomal copies, as has been observed previously following322
complementation of the essential MCA gene (Ambit et al., 2008). Integration into the 18s323
rRNA locus results in consistently high levels of expression (Misslitz et al., 2000) leading to324
non-physiological levels of CRK3 and subsequent CRK3:CYC6 activity at potentially325
inappropriate stages of the life cycle.326
327
The reduced growth rate of promastigotes overexpressing CRK3
T178E
is likely due to a partial328
dominant negative effect, whereby inactive CRK3
T178E
binds endogenous CYC6 leading to329
impaired protein kinase activity even in the presence of active CRK3. This reduced growth330
rate may explain both the cell cycle arrest at 72 h in the [SSU CRK3
T178E
] complemented line331
)LJ $ FRPSDUHG WR DUUHVW DW  KRXUV LQ ǻcrk3::DICREǻcrk3::CRK3Flox (Fig. 2B) and332
additionally the lower proportion of zoids when analysed by flow cytometry (Fig. 4C). The333
accumulation in G2/M suggests that mutation ablates CRK3:CYC6 activity, rather than334
CRK3:CYCA, where an increase of cells in G1/S might be anticipated. Both induced and335
XQLQGXFHG ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E] have dramatically reduced336
flagellum length and are immotile (Fig. 4D).. The reduced size of the flagellum and a growth337
defect are similar phenotypes to those observed in cell lines deficient in ATG5, a key338
component of the autophagic pathway (Williams et al., 2012). This is likely a result of their339
impaired ability to salvage material through the autophagic pathway, imparting selection on340
the parasites to reduce energy through flagellum regression. The partial dominant negative341
effect of CRK3
T178E
may also result in metabolic stress in these cells leading to the phenotype342
observed. The importance of T178 as an active site residue for regulating progression through343
G2/M implicates upstream modifiers of this residue as essential regulators of the L. mexicana344
cell cycle. In mammalian cells CDK7 acts as a CAK to regulate CDK1 by phosphorylation at345
this T-loop residue, yet no CAK homologues have been identified in the Leishmania genome346
(Gomes et al., 2010). The identification of potential post-transcriptional modifiers of the347
CRK3 T-loop residue that act in an analogous fashion to CDK7 would therefore yield348
promising targets for drug discovery. The phenotype of the induced cell line shows the349
importance of the T-loop residue for CRK3 activity and mitotic function within the cell,350
endorsing this complementation assay as a rational approach for active site investigation.351
352
The assessment of gene essentiality for amastigote viability is an important approach in the353
context of drug target validation as this life cycle stage is the pathologically significant form.354
The recent utilisation of plasmid shuffle has facilitated the study of Leishmania genes355
involved in life cycle differentiation and essentiality both in amastigote and promastigote356
forms by the generation of partial null mutants (Morales et al., 2010; Dacher et al., 2014).357
Retention of an episomal gene in a null mutant cell line after murine infection is a useful358
approach to assess that gene as necessary to amastigote survival in vivo (Wiese, 1998).359
Despite such elegant utilisation of reverse genetic methods to probe gene function, no method360
exists for the generation of conditional null mutants during in vivo infection. Our study does361
not address this lack directly due to the sensitivity of amastigotes to rapamycin, however as362
diCre activity remains high in stationary-phase promastigotes CRK3 was efficiently excised363
(Fig. 5B) to probe the subsequent infectivity of CRK3-deficient promastigotes. By tracking364
the progression of infection with reporter parasites expressing the highly sensitive red-shifted365
luciferase (Branchini et al., 2010; McLatchie et al., 2013) and by footpad size measurement,366
we demonstrate that the CRK3-deficient L. mexicana are unable to proliferate in their367
mammalian host (Figs. 5C, 5D and 5F). Importantly, the wild-type line expressing luciferase368
grows normally in mice following rapamycin treatment, which indicates that lack of growth369
of the CRK3-deficient mutant is not a result of the drug treatment. The average light370
intensities emitted from footpads infected with the wild-type [SSU RE9H) line and those from371
IRRWSDGVLQIHFWHGZLWKWKHǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H] line retaining floxed372
CRK3 are at similar levels throughout infection, yet mean footpad size is larger in wild-type373
[SSU RE9H] infected mice after 3 weeks post infection; such disagreement may be a result of374
the 5 fold lower signal intensity of the wild-type [SSU RE9H] compared with the375
experimental line (Fig. S5) and therefore an overall higher burden of the wild-type line is376
likely masked by a reduced bioluminescent signal intensity.377
378
Interestingly, parasite burden as measured by total flux remains consistently above the379
background intensity (dashed line, Fig. 5D) in those footpads infected with the CRK3-380
deficient line, suggestive of the survival of a low number of bioluminescent parasites. The381
outgrowth of these parasites was observed through an increased bioluminescence signal at 9382
weeks post infection compared with 5 weeks (Fig. 5C and 5D). Purification and PCR analysis383
of these parasites shows they retained the floxed CRK3 (Fig. 5E) and that the persistence of384
signal and subsequent increase are a result of incomplete excision of floxed CRK3 during the385
24 h incubation with rapamycin. These data further demonstrate the essentiality of CRK3386
activity for establishing infection.387
388
This is the first time an essential gene in promastigotes has been studied in vivo by389
conditional deletion, representing a useful tool to probe gene function. We are validating the390
feasibility of conditional gene deletion ex vivo and in vivo using rapamycin and non-immuno-391
inhibitory rapamycin analogues (‘rapalogs’), with such work being useful for the future of392
drug target validation. DiCre activity has been demonstrated in vivo (Jullien et al., 2007),393
however rapamycin treatment may be a limitation due to influence on the host immune394
response and on amastigote proliferation. Our attempts to study the effect of CRK3
Flox
395
deletion in lesion-derived amastigotes grown in axenic culture medium was problematic due396
to reduced proliferation of both experimental and wild-type L. mexicana at the relatively low397
dose of 50 nM rapamycin, therefore the use of rapalogs would be a rational approach for398
induction of diCre activity if they have reduced binding affinity for Leishmania TORs399
(Madeira da Silva and Beverley, 2010). A second generation diCre is currently in400
development and may present an alternative method for inducible gene deletion in vivo. In401
diCre2, each subunit is fused to mutant FKBP domains that are dimerised by the rapalog402
AP20187, which is amenable to in vivo use (Collins et al., 2013). Such a system could be403
applied for use in Leishmania and would complement our existing floxed gene replacement404
approach.405
406
In conclusion we have developed a highly efficient inducible gene deletion system that when407
used with transgene complementation allows for the first time the function of essential408
Leishmania genes to be elucidated. We have applied this approach to show that CRK3 is409
required for promastigote progression through mitosis, with gene deletion mutants showing a410
G2/M arrest and an accumulation of zoids, indicative of a lack of a cell cycle checkpoint in411
cytokinesis. Inducible deletion of CRK3 in stationary phase promastigotes attenuates412
infection in a murine host, providing further genetic validation of CRK3 as a potential drug413
target (Grant et al. 1998; Hassan et al. 2001; Grant et al. 2004; Gomes et al. 2010; Walker et414
al. 2011). Our diCre method provides a powerful tool for analysing genes essential for415
promastigote proliferation and to the study of the differentiation of promastigotes to416
amastigotes.417
418
Figure legends419
420
Fig. 1. Validation of inducible diCre in L. mexicana: conditional deletion of GFP in421
promastigotes and amastigotes.422
A. Gene excision analysed by PCR amplification. Schematic (lower) shows the SSU GFP
Flox
423
locus and the recombination event expected after treatment with rapamycin (Rap). (upper)424
PCR amplification with oligonucleotides 4287 and 4288 from experimental425
ǻcrk3::DICRE/CRK3 [SSU GFPFlox]) and control [SSU GFPFlox] promastigotes at 5 days426
post-treatment with different concentrations of rapamycin.427
B. Flow cytometry assessment of GFP intensity of experimental and control promastigotes428
incubated in the presence or absence of rapamycin for 5 days.429
C. Western blotting analysis with anti-GFP and anti-EF1D loading control antibodies of430
protein extracted from experimental promastigotes grown for 5 days in the presence or431
absence of 100 nM rapamycin.432
D. PCR analysis of GFP
Flox
loss (as described in A) in amastigotes after 24 h rapamycin433
treatment (0 – 1000 nM), followed by 120 h infection in bone-marrow derived macrophages.434
Lane 2 contains a 1 kb+ DNA ladder.435
436
Fig. 2. Generation of a CRK3 conditional deletion cell line.437
A. Schematic showing the replacement of endogenous CRK3 to generate438
ǻcrk3::DICREǻcrk3::CRK3Flox. One allele contains a loxP flanked CRK3-GFP coding439
sequence with mCherry red-fluorescent protein cassette (RFP) and puromycin drug selectable440
marker (PAC). The other allele contains genes encoding both diCre subunits (CRE59,441
CRE60) each linked with rapamycin binding domains (not shown: FKBP12 and FRB442
respectively) and a blasticidin resistance cassette (BSD). Each construct was flanked with 500443
bp arms of homology (light grey) by Gateway recombination to facilitate integration at the444
CRK3 locus. All coding sequences are flanked by regulatory elements (dark grey). L.445
mexicana parasites were transfected sequentially with the diCre construct and floxed CRK3446
to confer resistance to blasticidin and puromycin antibiotics respectively.447
B. Clones 2 and 8 promastigotes were seeded at a density of 5 x 10
5
cells ml
-1
and grown in448
the presence or absence (+/-) of 100 nM rapamycin for 5 days. Cell density was determined449
by counting at 24 h intervals and mean ± SD of triplicate values was plotted.450
C. (lower) A schematic representation of the floxed CRK3 locus after excision. PCR451
amplification shows the primers binding upstream of the 5’ CRK3 homologous flank and452
within the PAC cassette. (upper) PCR amplification of clones 2 and 8 at 24 h and 48 h +/-453
100 nM rapamycin treatment was conducted and the resulting amplicons resolved on an454
agarose gel.455
D. Western blotting analysis with anti-GFP and anti-EF1D loading control antibodies of456
protein extracted from experimental clone 2 promastigotes grown for 4 days in the presence457
or absence of 100 nM rapamycin.458
459
Fig. 3. Analysis of CRK3 deficient promastigotes.460
A. Representative images of cells grown in the absence (top) or presence (bottom two rows)461
of 100 nM rapamycin for 96 h. Promastigotes (clone 2) were stained with DAPI to observe462
nuclear and kinetoplast content alongside mCherry expression by fluorescence microscopy.463
6FDOHEDUUHSUHVHQWVȝP
B. (upper) DNA content analysis of clone 2 promastigotes at 72 and 96 h post treatment.465
Cells were fixed with methanol and stained with propidium iodide for flow cytometry466
analysis of 100,000 cells to examine nuclear content. Arrows indicate the positions of cells in467
G1 phase (2C), in G2/M (4C) and low DNA content associated with increased incidence of468
<1C zoids. (lower) Graphical representation of the DNA content of each population based on469
the flow cytometry plots.470
C. The viability of cells grown in the absence (-) or presence (+) of 100 nM rapamycin for 72471
h. Promastigotes (clone 2) were incubated with 5 µg ml
-1
propidium iodide (PI) for 15 min472
and analysed by flow cytometry. A heat lysed (HL) control in which half the sample was473
lysed by incubation at 70°C for 3 min was included to enable an appropriate live / dead gate474
to be drawn. Numbers represent the percentage of cells assessed as PI positive (PI+) based on475
the HL control. Data shown are the means of 3 technical replicates, data are representative of476
2 independent experiments.477
478
Fig. 4. CRK3 wild type and active site mutant complementation assays.479
$ :LOG W\SH FRPSOHPHQWHG ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3], left graph) and480
PXWDQW FRPSOHPHQWHG ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E], right graph) cell481
lines were seeded as promastigotes at 1 x 10
5
cells ml
-1
and grown +/- 100 nM rapamycin for482
5 days. Cell density was determined by counting at 24 h intervals and the mean ± SD of483
triplicate values was plotted.484
B. The resulting amplicons generated by PCR amplification of each cell line at 24 and 48 h485
after growth +/- 100 nM rapamycin.486
& OHIW '1$ FRQWHQW DQDO\VLV RI ǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E]487
promastigotes after methanol fixation and staining with propidium iodide for flow cytometry488
analysis (100,000 cells) to examine nuclear content. Arrows indicate the positions of cells in489
G1 phase (2C), in G2 (4C) and low DNA content associated with increased incidence of <2C490
zoids. (right) Graphical representation of the DNA content of each population based on the491
flow cytometry analysis.492
'5HSUHVHQWDWLYHLPDJHVRIǻcrk3::DICREǻcrk3::CRK3Flox [SSU CRK3T178E] promastigotes493
grown in the absence (top) or presence (bottom two rows) of 100 nM rapamycin for 96 h.494
Parasites were stained with DAPI to detect nuclear and kinetoplast DNA by fluorescence495
PLFURVFRS\6FDOHEDUUHSUHVHQWVȝP
497
Fig. 5. CRK3 conditional deletion in stationary phase promastigotes and in vivo infection.498
A. Correlation between in vivo bioluminescence (total flux in photons per second) and499
parasite burdens from the same infected footpads. BALB/c mice were infected with L.500
mexicana WT or Ppy RE9H-expressing stationary phase promastigotes and imaged weekly501
using an in vivo imaging system (IVIS). At 2, 4, 6 and 8 weeks post-infection mice were502
sacrificed after imaging and parasite burdens in infected footpads determined using limiting503
dilution assays. Each point shows the total flux and parasite burden from the footpad in one504
mouse (n = 3-4 mice per time point). Linear regression line and R
2
was calculated from the505
log transformed data.506
B. PCR amplification of the floxed CRK3 ORFXV RI ǻcrk3::DICREǻcrk3::CRK3Flox [SSU507
RE9H] stationary phase promastigotes after incubation in the presence (+) or absence (-) of 1508
ȝ0UDSDP\FLQIRUK
C. Control (-) or 24 h rapamycin-treated (+) stationary phase promastigotes were inoculated510
into the footpads of BALB/c mice. The total flux (photons/sec) emitted from the infected511
footpad region of interest (ROI) was quantified weekly.512
D. The total flux measured from infected footpads was plotted over 9 weeks of infection.513
Data shown represent the mean flux and SD from groups of four mice. The dotted line514
indicates the average background flux emitted from uninfected footpads measured 1 week515
post infection (n=12). A significant difference in the mean total flux emitted between the516
footpads of mice infected with untreated and rapamycin-induced parasites was observed at 5517
and 9 weeks post infection (2-way ANOVA, ***P=<0.001;**P=<0.005).518
E. PCR amplification of the floxed CRK3 ORFXV RI ǻcrk3::DICREǻcrk3::CRK3Flox [SSU519
RE9H] + Rap after purification of amastigotes from the footpads of 10-week infected mice.520
Cells were propagated in vitro to obtain sufficient genomic DNA for PCR analysis.521
F. Footpad sizes were recorded by weekly caliper measurement. Data shown represent the522
mean footpad size and SD from groups of four mice (Unpaired t-test *P=<0.05).523
524
525
Table 1. Comparisons of the growth rates of conditional CRK3 deletion lines measured526
during logarithmic growth.527
528
Experimental Procedures529
Ethics statement530
Animal studies were carried out under UK Home Office regulations (Project licence PPL531
60/4442).532
Parasite culture and transfection533
Leishmania mexicana mexicana (MNYC/BZ/62/M379) promastigotes were cultured at 25°C534
in HOMEM supplemented with 10% heat inactivated foetal calf serum (HI-FCS) and 1%535
penicillin/streptomycin (PEN/STREP). Amastigotes were cultured in Schneider’s Insect536
0HGLXPVXSSOHPHQWHGZLWK+,)&63(1675(3DQGȝJP/-1 Hemin at pH5.5.537
Mid-log phase L. mexicanaSURPDVWLJRWHVZHUH WUDQVIHFWHGZLWKȝJRIGLJHVWHG'1$E\
electroporation using the Nucleofector system with the Human T-Cell kit (Lonza) as539
described previously (Castanys-Muñoz et al., 2012). Transgenic cell lines were grown in the540
SUHVHQFH RI DSSURSULDWH DQWLELRWLFV DW WKH IROORZLQJ FRQFHQWUDWLRQV *  ȝJ P/-1,541
EODVWLFLGLQȝJP/-1DQGSXURP\FLQȝJP/-1 (InvivoGen).542
Construct design and development543
A full list and descriptions of all primers (Table S1) and plasmids (Table S2) used in this544
study are available. To produce a diCre expression vector, the diCre coding sequences Cre59-545
FKBP12 and Cre60-FRB were each flanked by actin and E-tubulin sequences in array with546
blasticidin resistance cassette flanked by DHFR-TS regulatory elements. The sequence was547
synthesised and sub-cloned into the pDONR221 vector (GenScript). The backbone of the548
loxP vector containing the loxP sites flanking a multiple cloning site and other restriction549
enzyme regions flanked by regulatory elements was synthesised (GenScript). The PAC,550
mCherry and CRK3-GFP cassettes were inserted by enzymatic restriction digest mediated551
ligation, and subsequently sub-cloned into pDONR221. Addition of CRK3 homology552
flanking homology was performed by MultiSite Gateway 3-fragment vector construction553
(Invitrogen) as per manufacturers’ guidelines. Briefly, flanks were amplified by PCR by554
Phusion polymerase (New England BioLabs) using oligonucleotides conferring attB555
recombination sites to the amplicons. Subsequent BP reactions inserted the flanks into556
appropriate pDONR vectors containing attL sites for site-specific recombination. An LR557
reaction resulted in the flanking of diCre and loxP vectors into a pDEST vector for558
transfection. Finally, complementation plasmids were generated by inserting the CRK3,559
CRK3
T178E
and RE9H genes (Branchini et al., 2010; McLatchie et al., 2013) into a modified560
version of pGL631 (Misslitz et al., 2000) containing a G418r cassette for SSU integration561
construct by XhoI & NotI restriction enzyme digestion and ligation.562
Induction of diCre mediated gene deletion563
All experiments were conducted using cells in the early to mid log stage of exponential564
growth (between 1-5 x 10
6
cells mL
-1
) with the exception of the stationary phase inducible565
JHQH GHOHWLRQ %HWZHHQ Q0 WR ȝ0 UDSDP\FLQ $EFDP ZDV DGPLQLVWHUHG E\ LQRFXODWLRQ
LQWRWKHFHOOFXOWXUHPHGLXPIURPDȝ0ZRUNLQJVWRFN
Conditional gene deletion analysis568
Taq polymerase (NEB) was used to PCR amplify the regions surrounding GFP
Flox
and569
CRK3
Flox
using primers shown in Table S1 and a TA calculated using an online Tm calculator570
(New England BioLabs) and 30 cycles for amplification.571
Western Blot Analysis572
For western blotting analysis, either 1 x 10
7
cells were loaded per lane or equal573
concentrations of protein extract as quantified by Bradford assay of a 10% NuPAGE Bis-Tris574
gel (Invitrogen) in MOPS running buffer and transferred onto Hybond-C nitrocellulose575
membranes (GE Healthcare). Primary antibodies against GFP were used to detect GFP and576
CRK3-GFP expression at 1:1000 whilst anti-EF1D was used as a loading control at 1:5000.577
Membranes were washed three times in TBST, incubating for 10 min each time, before578
incubation with horse radish peroxidase (HRP)-conjugated secondary rabbit and mouse579
antibodies at 1:5000 dilution for 1 h at room temperature. After washing three times in TBST,580
the membrane was treated with an ECL (enhanced chemiluminescence) kit (SuperSignal581
West Pico Chemoluminescent Substrate, Pierce) according to manufacturer’s instructions and582
then exposed on Kodak photographic film.583
Infection of mice584
BALB/c mice were purchased from Charles River (MA., USA) and infected in the right585
footpad with 2 x 10
6
stationary-phase L. mexicana promastigotes in 1 x PBS. Lesion size was586
PRQLWRUHGZHHNO\DQGǻcrk3::DICRE/CRK3 [SSU GFPFlox] amastigotes were purified before587
the lesions reached a thickness of 5mm.588
Purification of lesion derived amastigotes589
/HVLRQ GHULYHG ǻcrk3::DICRE/CRK3 [SSU GFPFlox] amastigotes were purified by590
KRPRJHQLVLQJ WKHH[WUDFWHG OHVLRQ LQ[3%6DQGSDVVLQJ WKHVROXWLRQ WKURXJKDȝPFHOO
strainer. Amastigotes were pelleted by centrifugation at 2,000 g for 10 mins, followed by re-592
suspension in culture medium. To prevent cells from clumping together and ensure accurate593
cell counting, amastigote cultures were first centrifuged at 2,000 g for 10 mins and the594
supernatant removed to leave the pellet in 500uL volume. The pellet was re-suspended in this595
volume by gentle syringing through a blunt 16G needle and the single cell suspension added596
back to the culture medium. Cell counting was performed by mixing the homogenised culture597
1:1 with Trypan blue and cell counting with a Haemocytometer (Neubauer).598
Macrophage differentiation and amastigote infection599
Non-differentiated monocytes were extracted from the femurs and tibia of BALB/c mice by600
dissection to remove the bones. RPMI 1640 medium was used to wash the bone marrow out601
of the intact bones by syringing with a 25G needle. Extracted cells were quantified by602
dilution in Trypan blue (1:1) and counting with a haemocytometer. Monocytes were seeded at603
5x10
5
cells ml
-1LQ0ĭ0HGLXP'0(0/*OXW)&636/&HOO0LQ
8 ml volumes in Petri dishes and incubated at 37°C with 5% CO2 for 3 days to induce605
differentiation to monocyte-derived macrophage. After this period the medium was replaced606
and by day 5 the cells were removed from the dishes using a cell scraper with ice- cold RPMI607
1640. Bone marrow derived macrophage were adhered at a concentration of 5 x 10
5
cells ml
-1
608
overnight in DMEM medium with 10 % HIFCS at 37°C in 5% CO2 onto 8-chamber tissue609
culture slides (LAB-TEK) for microscopic analysis or 12 well plates for DNA extraction and610
flow cytometry analysis. Macrophages were then infected at a ratio of 5 parasites per611
PDFURSKDJHZLWKOHVLRQGHULYHGǻcrk3::DICRE/CRK3 [SSU GFPFlox] amastigotes, which had612
been previously grown in axenic medium in the presence or absence of rapamycin for 24 h.613
Wells were washed at 24 h post infection to remove extracellular parasites and media614
replenished with DMEM/10% HIFCS. Cells were removed from the plates for DNA615
extraction and flow cytometry analysis by gentle scraping in ice cold RPMI at the 120 h end616
time point.617
Fluorescence microscopy analysis618
For imaging, 2 x 10
6
parasites were washed in 1 x PBS, re-suspended in Fluoromount-G619
(SouthernBiotech) DAPI infused mounting medium and mounted on glass slides for analysis.620
Parasite morphology was observed by DIC and mCherry fluorescent imaging, and DNA621
content observed by DAPI fluorescent imaging using a Delta Vision core (Image Solutions)622
inverted microscope equipped with mCherry and DAPI filter sets. Images were processed623
using Photoshop CS (Adobe) image software. GFP expression of intracellular amastigotes624
was assessed by fluorescent microscopy. Cells were imaged between 24 and 120 h after625
infection in the DeltaVision Core environmental chamber at 37°C and 5 % CO2 upon626
incubation in 1 x PBS infused with DAPI.627
DNA content and GFP expression analysis by flow cytometry628
Parasites were prepared for DNA content analysis as described previously (Paul Hassan et629
al., 2001) with the exceptions that a MacsQuant flow cytometer was used to analyse 100,000630
cells per sample. Cell distribution was modelled using FlowJo software (Tree Star). For631
determining GFP expression of promastigotes and amastigotes by flow cytometry analysis,632
live cells were washed twice in 1xPBS and passed through a nitex mesh prior to acquisition.633
Viability assay634
Log-phase promastigotes were seeded at 5 x 10
5
cells ml
-1
and grown in the presence or635
absence of 100 nM rapamycin. At 72 h post treatment 1 x 10
7
cells were washed once with 1636
x PBS and incubated with 5ug ml
-1
propidium iodide (PI) for 15 minutes at room temperature637
in the dark. A heat lysed (HL) control in which half the sample was lysed by incubation at638
70°C for 3 min was included to enable an appropriate live / dead gate to be drawn. Cells were639
washed with 1 x PBS and used to acquire 100,000 events per group by flow cytometry using640
a MacsQuant flow cytometer.641
In vivo imaging642
For imaging, mice were anaesthetised with 4.0% isofluorane/1.5 L O2 per minute and643
LQRFXODWHGE\VXEFXWDQHRXVLQMHFWLRQZLWKȝO'OXFLIHULQPJPO-1 in Mg/Ca-free644
Dulbecco’s modified PBS). Light emission was recorded 10 minutes after inoculation using645
an IVIS Spectrum bioluminescence imaging system (PerkinElmer). Imaging was performed646
with an open emission filter, for 30-60 second exposures, large binning, and 1 f/stop, and647
captured with a charge-coupled device (CCD) camera. The absolute unit of photon emission648
was given as radiance (photons /second/cm
2
/steradian). Images were analysed using Living649
Image Software (PerkinElmer) and regions of interest (ROI) of equal size were selected over650
the infected footpads to quantify the amount of photon emission as total photon flux in651
photons per second (photons/sec).652
Statistical analysis653
Statistical analysis was performed using GraphPad Prism 5. The analysis of significance of654
the data was performed by 2-way ANOVA when comparing data from induced (+Rap) and655
XQLQGXFHG5DSǻcrk3::DICREǻcrk3::CRK3Flox [SSU RE9H] infections and by paired t-test656
when comparing footpad sizes.657
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Fig. S1. A. Replacement of a single copy of CRK3 by diCre construct integration into the 
[SSU GFP Flox] cell line was confirmed by PCR amplification of genomic DNA extracted 
from two clones (3 and 4). Oligonucleotides (OL) that bind outside the integration site (grey 
arrows) and within the diCre coding sequence (red arrows) were used to amplify 940 bp and 
950 bp amplicons. Clone 3 was designated as the experimental line ǻcrk3::DICRE/CRK3 
[SSU GFPFlox].  
B. ([SHULPHQWDOǻcrk3::DICRE/CRK3 [SSU GFPFlox] or control [SSU GFPFlox] L. mexicana 
promastigotes were seeded at 1x106 cells ml-1 and incubated in the presence or absence of 
between 1 to 250 nM rapamycin. Cell density was determined at 24 hour intervals by cell 
counting (N=1-3 technical replicates, error SEM).  
C. Representative DIC (upper) and GFP (lower) images from live cell imaging of 
amastigotes-infected macrophages at 5 days post-infection. GFP expression from live 
amastigotes was imaged using a Delta Vision core fluorescent microscope.  
D. GFP intensity loss in amastigotes extracted at day 5 post in vitro macrophage infection; 
(left) amastigotes were gated from large, granular macrophage by forward scatter (FSC) for 
size and side-scatter (SSC) for granularity. (middle) Histograms of amastigote GFP intensity 
were generated from amastigote gates with retention of GFP expression at >103 fluorescence 
intensity based on rapamycin untreated controls. Blue plots represent the amastigote gate 
plotted from a macrophage only control group to represent background FHOOXODUµGHEULV¶DVD
result of macrophage lysis following sample preparation (left). >20,000 amastigote events 
were analysed per treatment group based on two biological replicates shown as dark and light 
grey plots. (right) Retention of GFP signal as a % of amastigote gate displayed as bar graphs 
for each treatment group (Data represent means ± SEM).  
  
  
 
Fig. S2. Pipeline of Gateway-mediated addition of target gene homologous flanks to diCre 
and loxP vectors. (1) 3ULPHUV EOXH DUURZV FRQWDLQLQJ DSSURSULDWH DWW VLWHV DQG ¶ PacI or 
¶PmeI unique restriction sites amplify a 0.5-1 kb region up- and downstream of the gene. (2) 
BP clonase catalyses the insertion of these flanks into their appropriate vectors. (3) The 
UHVXOWLQJ¶ ¶DQGGL&UHRUOR[3YHFWRUVDUHUHFRPELQHGLQWRDS'(67YHFWRUE\/5FORQDVH. 
(4) The final vector is linearised by PacI and PmeI digest for (5) transfection into L. 
mexicana. This method enables flanking of both the floxed gene of interest (GOI) expression 
cassette and diCre expression cassette.  
 
Fig. S3. A. Schematic representing the diCre and floxed CRK3 replacement strategy. 
Homologous recombination was facilitated by Gateway flanking of both diCre and loxP 
vectors with ~500 bp of crk3 ¶DQG¶KRPRORJRXVUHJLRQVWRreplace both alleles.  
B. Transfection of wild-type L. mexicana with the diCre construct: integration was confirmed 
by PCR amplification of genomic DNA extracted from six clones with oligonucleotides (OL) 
binding outside the integration site (grey arrows) and within the diCre coding sequence (blue 
arrows) to amplify 940 and 950 bp amplicons. A single blasticidin (BSD) resistant clone F 
with diCre integrated at the crk3 locus was subsequently transfected with the loxP construct 
to replace the remaining endogenous crk3 allele with a floxed CRK3 IXVHGWRD¶GFP tag, 
thereby generating a diCre-meGLDWHGFRQGLWLRQDOGHOHWLRQOLQHǻcrk3::DICRE/ 
ǻcrk3::CRK3Flox. PCR amplification of genomic DNA extracted from two blasticidin/ 
puromycin (PUR) double resistant clones (2 and 8) with oligonucleotides binding outside the 
integration site (grey arrows), within the crk3 coding sequence (grey arrows), within the loxP 
vector (blue arrows) and diCre sequences (red arrows).  
  
 Figure S4. Viability assay of ǻcrk3::DICREǻcrk3::CRK3Flox promastigotes. Cells were 
grown in the presence or absence of 100 nM rapamycin for 72 h. Live cells were incubated 
with 5ug ml-1 propidium iodide (PI) for 15 minutes and uptake measured by flow cytometry 
alongside a heat lysed (HL) control in which half the cells were lysed by incubation at 70°C 
for 3 min prior to flow cytometry analysis. Top panel shows cell size as measured by forward 
scatter in the y-axis and cell lysis by increasing PI fluorescence along the x-axis. Bottom left 
panel shows the gating strategy whereby cells are defined as + or ± in PI uptake based on the 
HL control. Bottom right panel is an analysis of promastigote cell size following incubation 
in the presence or absence of rapamycin. Results are representative of 2 independent 
experiments.  
  
 Figure S5. In vitro bioluminescence expression assay of experimental and control 
promastigotes. Promastigotes were assayed during logarithmic growth and luminescence 
expression data was acquired 30 minutes post luciferin treatment. Error bars represent the 
SEM of two technical replicates per clone.  
 
  
  
 
Table S1. A list of the oligonucleotides used in this study.  
  
  
Table S2. A list of the plasmids generated in this study.  
 
